Literature DB >> 26707612

The experience of patients with early-stage testicular cancer during the transition from active treatment to follow-up surveillance.

Abra H Shen1, Doris Howell2, Elizabeth Edwards1, Padraig Warde3, Andrew Matthew4, Jennifer M Jones5.   

Abstract

PURPOSE: To gain a better understanding of the experiences of patients with early-stage testicular cancer during the transition from active cancer treatment to follow-up care.
MATERIALS AND METHODS: Cross-sectional multimethod study (questionnaires, focus groups, and telephone interviews) to describe experiences of patients with testicular cancer transitioning to survivorship. Questionnaire package included standardized measures of survivorship knowledge, feeling of preparedness, health-related distress, and perspectives on care coordination. Standard descriptive statistics and Mann-Whitney tests to examine associations between all outcomes based on demographic and clinical variables were performed. Qualitative results (focus groups and interviews) were analyzed with qualitative content analysis.
RESULTS: Based on quantitative data (n = 90) and qualitative analyses (n = 13), participants had relatively high survivorship knowledge, most testicular cancer survivors were not provided with any formal transition planning or documentation, and a substantial minority felt unprepared to cope with the aftereffects of testicular cancer and the posttreatment survivorship phase. Younger men had lower survivorship knowledge, feelings of preparedness, and continuity of care scores and were less likely to report having received any self-management tools and education or information of patient resources. Participants reported that they did not know what to expect physically or emotionally after treatment ended and many continued to be frustrated and worried about their health problems. They expressed the need for reliable and personalized resources on what to expect after treatment and more formal transition care planning.
CONCLUSIONS: Patients with testicular cancer continue to struggle in their transition to posttreatment survivorship. Quality of care must emphasize a shift from a purely disease-focused approach to a wellness-centered approach that provides coordinated, patient-centered, and comprehensive care to optimize quality of life for these survivors.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health care delivery; Supportive care; Survivorship; Testicular cancer

Mesh:

Year:  2015        PMID: 26707612     DOI: 10.1016/j.urolonc.2015.09.016

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

Review 1.  Testicular cancer survivorship: Long-term toxicity and management.

Authors:  Noa Shani Shrem; Lori Wood; Robert J Hamilton; Kopika Kuhathaas; Piotr Czaykowski; Matthew Roberts; Andrew Matthew; Jason P Izard; Peter Chung; Lucia Nappi; Jennifer Jones; Denis Soulières; Armen Aprikian; Nicholas Power; Christina Canil
Journal:  Can Urol Assoc J       Date:  2022-08       Impact factor: 2.052

2.  Oleuropein Counteracts Both the Proliferation and Migration of Intra- and Extragonadal Seminoma Cells.

Authors:  Sabrina Bossio; Anna Perri; Rocco Malivindi; Francesca Giordano; Vittoria Rago; Maria Mirabelli; Alessandro Salatino; Antonio Brunetti; Emanuela Alessandra Greco; Antonio Aversa
Journal:  Nutrients       Date:  2022-05-31       Impact factor: 6.706

3.  Online information and support needs of young people with cancer: a participatory action research study.

Authors:  Sarah Lea; Ana Martins; Sue Morgan; Jamie Cargill; Rachel M Taylor; Lorna A Fern
Journal:  Adolesc Health Med Ther       Date:  2018-09-17

4.  Still lost in transition: a qualitative descriptive study of people's experiences following treatment completion for haematological cancer in Wales, UK.

Authors:  Tessa E Watts; Janet Bower
Journal:  Ecancermedicalscience       Date:  2019-12-12

Review 5.  The impact of testicular cancer and its treatment on masculinity: A systematic review.

Authors:  Victoria Dax; Maria Ftanou; Ben Tran; Jeremy Lewin; Rebecca Wallace; Zac Seidler; Joshua F Wiley
Journal:  Psychooncology       Date:  2022-07-21       Impact factor: 3.955

6.  Identification of potential core genes and miRNAs in testicular seminoma via bioinformatics analysis.

Authors:  Kai Wang; Yun Chen; Zhihong Zhao; Meiying Feng; Shouquan Zhang
Journal:  Mol Med Rep       Date:  2019-09-16       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.